Living With GIST: 10 Years of Molecularly Targeted Therapy
|Posted by Julie Royster (juliecontent) on May 01 2010|
|GIST In the News >>|
On April 9 GIST patients and familiy members flocked to Dana-Farber for a day-long event organized by George Demetri, MD and Suzanne George, MD to celebrate the 10-year anniversary of the first drug for treatment of GIST, imatinib (Gleevec).
Below are some photos from this memorable event!
A panel of GIST patients from the original B2222 trial told their stories as 10-year-plus survivors.
Les Anderhub tells his story...
Dr. Demetri introduces the expert panelists: Burton Eisenberg, MD; Annick van den Abbeele, MD, Meg von Mehren, MD; Charles Blanke, MD; and Christopher Corless, MD.
Dr. Ed Benz, head of Dana-Farber Cancer Institute, addresses the crowd.
Dr. Demetri and Dorothy McBride.
Dr. Eisenberg converses with Brian McBride.
A group of patients met for dinner the night before the event.
Marina met up with Barbara.
Last changed: Aug 11 2010 at 2:05 PMBack